Ultradeformable cationic liposomes for delivery of small interfering RNA (siRNA) into human primary melanocytes

被引:65
作者
Geusens, B. [1 ]
Lambert, J. [1 ]
De Smedt, S. C. [2 ]
Buyens, K. [2 ]
Sanders, N. N. [2 ,3 ]
Van Gele, M. [1 ]
机构
[1] Ghent Univ Hosp, Dept Dermatol, B-9000 Ghent, Belgium
[2] Univ Ghent, Lab Gen Biochem & Phys Pharm, B-9000 Ghent, Belgium
[3] Univ Ghent, Lab Gene Therapy, Dept Nutr Genet & Ethol, Fac Vet Med, B-9820 Merelbeke, Belgium
关键词
Ultradeformable liposomes; Delivery vehicle; Skin; Melanocytes; siRNA; DRUG CARRIERS; TRANSDERMAL DELIVERY; TRIAMCINOLONE-ACETONIDE; TRANSFECTION EFFICIENCY; TOPICAL APPLICATION; INTACT SKIN; DNA; VESICLES; EXPRESSION; IMMUNIZATION;
D O I
10.1016/j.jconrel.2008.10.003
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The aim of this work was to develop a system that can deliver siRNA into cells present in the human epidermis. More specifically, we wanted to block the expression of a specific Myosin Va exon F containing isoform that is physiologically involved in melanosome transport in human melanocytes. Therefore, we prepared and investigated the capacity of ultradeformable cationic liposomes (UCLs) to deliver siRNA in hard-to-transfect human primary melanocytes. UCLs were formulated from different w:w ratios (6:1, 8:1 and 10:1) of the cationic lipid 1,2-dioleoyl-3-trimethylammonium propane (DOTAP) and the edge activator sodium cholate. Subsequently, UCL/siRNA complexes were prepared and their particle size, surface charge, deformability, cytotoxicity, transfection efficiency and long-term stability were tested. The best results were obtained with UCLs composed of a DOTAP/NaChol ratio of 6:1 (w:w) which are promising for future in vivo experiments. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:214 / 220
页数:7
相关论文
共 50 条
[21]   Anionic polymers for decreased toxicity and enhanced in vivo delivery of siRNA complexed with cationic liposomes [J].
Schlegel, Anne ;
Largeau, Celine ;
Bigey, Pascal ;
Bessodes, Michel ;
Lebozec, Kristell ;
Scherman, Daniel ;
Escriou, Virginie .
JOURNAL OF CONTROLLED RELEASE, 2011, 152 (03) :393-401
[22]   Comparative cellular pharmacokinetics and pharmacodynamics of siRNA delivery by SPANosomes and by cationic liposomes [J].
Zhou, Chenguang ;
Zhang, Yue ;
Yu, Bo ;
Phelps, Mitch A. ;
Lee, L. James ;
Lee, Robert J. .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2013, 9 (04) :504-513
[23]   A review of nanocarriers for the delivery of small interfering RNA [J].
Kesharwani, Prashant ;
Gajbhiye, Virendra ;
Jain, Narendra Kumar .
BIOMATERIALS, 2012, 33 (29) :7138-7150
[24]   Noninvasive approach for enhancing small interfering RNA delivery percutaneously [J].
Aljuffali, Ibrahim A. ;
Lin, Yin-Ku ;
Fang, Jia-You .
EXPERT OPINION ON DRUG DELIVERY, 2016, 13 (02) :265-280
[25]   siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes [J].
Hattori, Yoshiyuki ;
Nakamura, Ayako ;
Arai, Shohei ;
Kawano, Kumi ;
Maitani, Yoshie ;
Yonemochi, Etsuo .
JOURNAL OF LIPOSOME RESEARCH, 2015, 25 (04) :279-286
[26]   Development of edge-activated liposomes for siRNA delivery to human basal epidermis for melanoma therapy [J].
Dorrani, Mania ;
Garbuzenko, Olga B. ;
Minko, Tamara ;
Michniak-Kohn, Bozena .
JOURNAL OF CONTROLLED RELEASE, 2016, 228 :150-158
[27]   Small interfering RNA targeting the human myostatin gene [J].
Furalyov, V. A. ;
Kravchenko, I. V. ;
Popov, V. O. .
MOLECULAR BIOLOGY, 2009, 43 (04) :586-590
[28]   Cationic Liposomal Co-delivery of Small Interfering RNA and a MEK Inhibitor for Enhanced Anticancer Efficacy [J].
Kang, Seung Hee ;
Cho, Hee-Jeong ;
Shim, Gayong ;
Lee, Sangbin ;
Kim, Su-Hyeon ;
Choi, Han-Gon ;
Kim, Chan-Wha ;
Oh, Yu-Kyoung .
PHARMACEUTICAL RESEARCH, 2011, 28 (12) :3069-3078
[29]   Cationic Liposomal Co-delivery of Small Interfering RNA and a MEK Inhibitor for Enhanced Anticancer Efficacy [J].
Seung Hee Kang ;
Hee-Jeong Cho ;
Gayong Shim ;
Sangbin Lee ;
Su-Hyeon Kim ;
Han-Gon Choi ;
Chan-Wha Kim ;
Yu-Kyoung Oh .
Pharmaceutical Research, 2011, 28 :3069-3078
[30]   Nanovehicle-based Small Interfering RNA (siRNA) Delivery for Therapeutic Purposes: A New Molecular Approach in Pharmacogenomics [J].
Akhtari, Javad ;
Tafazoli, Alireza ;
Mehrad-Majd, Hassan ;
Mahrooz, Abdolkarim .
CURRENT CLINICAL PHARMACOLOGY, 2018, 13 (03) :173-182